| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
AR
|
androgen receptor
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CA9
|
carbonic anhydrase IX
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CASC4
|
cancer susceptibility candidate 4
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAST
|
calpastatin
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCNA2
|
cyclin A2
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNG2
|
cyclin G2
|
|
CD24
|
CD24 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDC25A
|
cell division cycle 25A
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDR2
|
cerebellar degeneration-related protein 2, 62kDa
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CHEK1
|
checkpoint kinase 1
|
|
CMTM5
|
CKLF-like MARVEL transmembrane domain containing 5
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTTN
|
cortactin
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F2
|
E2F transcription factor 2
|
|
ECD
|
ecdysoneless homolog (Drosophila)
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
EMP3
|
epithelial membrane protein 3
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHB4
|
EPH receptor B4
|
|
EPOR
|
erythropoietin receptor
|
|
EPX
|
eosinophil peroxidase
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV4
|
ets variant 4
|
|
EZR
|
ezrin
|
|
F11R
|
F11 receptor
|
|
FASN
|
fatty acid synthase
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FHIT
|
fragile histidine triad
|
|
FOXM1
|
forkhead box M1
|
|
GATA4
|
GATA binding protein 4
|
|
GLS
|
glutaminase
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar)
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
H2AFY
|
H2A histone family, member Y
|
|
HDAC6
|
histone deacetylase 6
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HPSE
|
heparanase
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
INSL4
|
insulin-like 4 (placenta)
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IQSEC1
|
IQ motif and Sec7 domain 1
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
JAK2
|
Janus kinase 2
|
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT6A
|
keratin 6A, type II
|
|
KRT6B
|
keratin 6B, type II
|
|
KRT7
|
keratin 7, type II
|
|
KRT8
|
keratin 8, type II
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LETMD1
|
LETM1 domain containing 1
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
MAGEA11
|
melanoma antigen family A11
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MED1
|
mediator complex subunit 1
|
|
MED23
|
mediator complex subunit 23
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIR139
|
microRNA 139
|
|
MIR190A
|
microRNA 190a
|
|
MIR19A
|
microRNA 19a
|
|
MIR200B
|
microRNA 200b
|
|
MIR21
|
microRNA 21
|
|
MIR331
|
microRNA 331
|
|
MIR630
|
microRNA 630
|
|
MIR93
|
microRNA 93
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NEK2
|
NIMA-related kinase 2
|
|
NFIB
|
nuclear factor I/B
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NRG1
|
neuregulin 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PGR
|
progesterone receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PIP
|
prolactin-induced protein
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCI
|
protein kinase C, iota
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK6
|
protein tyrosine kinase 6
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPN18
|
protein tyrosine phosphatase, non-receptor type 18 (brain-derived)
|
|
PXN
|
paxillin
|
|
RAB5A
|
RAB5A, member RAS oncogene family
|
|
RAD21
|
RAD21 homolog (S. pombe)
|
|
RAG2
|
recombination activating gene 2
|
|
RB1
|
retinoblastoma 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REST
|
RE1-silencing transcription factor
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
S100A14
|
S100 calcium binding protein A14
|
|
S1PR4
|
sphingosine-1-phosphate receptor 4
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STARD10
|
StAR-related lipid transfer (START) domain containing 10
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THEMIS2
|
thymocyte selection associated family member 2
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TRMT2A
|
tRNA methyltransferase 2 homolog A (S. cerevisiae)
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TYMS
|
thymidylate synthetase
|
|
UROD
|
uroporphyrinogen decarboxylase
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VIM
|
vimentin
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
|
WNT10B
|
wingless-type MMTV integration site family, member 10B
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
WWP1
|
WW domain containing E3 ubiquitin protein ligase 1
|
|
YBX1
|
Y box binding protein 1
|
